KOBO BIOTECH LIMITED (KOBO.BO)
INR 2.96
(4.96%)
INR 2.96
(4.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 713.93 Million INR | -5.23% |
| 2022 | 753.3 Million INR | -4.87% |
| 2021 | 791.85 Million INR | -65.66% |
| 2020 | 2.3 Billion INR | -2.43% |
| 2019 | 2.36 Billion INR | -1.3% |
| 2018 | 2.39 Billion INR | -2.64% |
| 2017 | 2.45 Billion INR | -2.49% |
| 2016 | 2.52 Billion INR | -3.17% |
| 2015 | 2.6 Billion INR | 3.43% |
| 2014 | 2.51 Billion INR | -9.74% |
| 2013 | 2.79 Billion INR | -32.23% |
| 2012 | 4.11 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 713.93 Million INR | -5.23% |
| 2023 Q4 | 713.93 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 733.36 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 771.86 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 753.3 Million INR | -4.87% |
| 2022 Q4 | 753.3 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 1.46 Billion INR | 0.0% |
| 2021 Q4 | 791.85 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 791.85 Million INR | -65.66% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 2.33 Billion INR | 0.0% |
| 2020 Q4 | 2.3 Billion INR | 0.0% |
| 2020 FY | 2.3 Billion INR | -2.43% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 2.36 Billion INR | -1.3% |
| 2019 Q2 | 2.36 Billion INR | 0.0% |
| 2019 Q4 | 2.36 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q2 | 2.4 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 2.39 Billion INR | 0.0% |
| 2018 FY | 2.39 Billion INR | -2.64% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q2 | 2.49 Billion INR | 0.0% |
| 2017 FY | 2.45 Billion INR | -2.49% |
| 2017 Q4 | 2.45 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 FY | 2.52 Billion INR | -3.17% |
| 2016 Q4 | 2.52 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 2.55 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 FY | 2.6 Billion INR | 3.43% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 2.6 Billion INR | 0.0% |
| 2015 Q2 | 2.57 Billion INR | 0.0% |
| 2014 FY | 2.51 Billion INR | -9.74% |
| 2014 Q4 | 2.51 Billion INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2013 FY | 2.79 Billion INR | -32.23% |
| 2012 FY | 4.11 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ANG Lifesciences India Limited | 2.42 Billion INR | 70.552% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | 43.318% |
| Bacil Pharma Limited | 13.26 Million INR | -5283.719% |
| BDH Industries Limited | 934.11 Million INR | 23.571% |
| Beryl Drugs Limited | 174.86 Million INR | -308.268% |
| Cian Healthcare Limited | 1.61 Billion INR | 55.705% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -448.539% |
| Concord Drugs Limited | 588.06 Million INR | -21.404% |
| Deccan Health Care Limited | 1.08 Billion INR | 33.924% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -112.272% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -206.759% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 67.712% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -2015.801% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | 56.757% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -560.519% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 81.889% |
| Panchsheel Organics Limited | 1.59 Billion INR | 55.114% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | 28.583% |
| Parnax Lab Limited | 1.88 Billion INR | 62.179% |
| Makers Laboratories Limited | 1.61 Billion INR | 55.727% |
| Medi-Caps Limited | 1.27 Billion INR | 43.91% |
| MedPlus Health Services Limited | 30.04 Billion INR | 97.624% |
| Phaarmasia Limited | 314.47 Million INR | -127.022% |
| Parmax Pharma Limited | 176.12 Million INR | -305.354% |
| Patidar Buildcon Limited | 94.27 Million INR | -657.282% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -64.481% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -3956.218% |
| Trident Lifeline Limited | 870.76 Million INR | 18.01% |
| Tyche Industries Limited | 1.36 Billion INR | 47.85% |
| Vivanza Biosciences Limited | 195.01 Million INR | -266.094% |
| PRAVEG LIMITED | 3.64 Billion INR | 80.418% |
| Smruthi Organics Limited | 1.18 Billion INR | 39.595% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -201.866% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 74.784% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 93.79% |
| Transchem Limited | 763.18 Million INR | 6.453% |
| Trinity League India Limited | 32.38 Million INR | -2104.456% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | 49.961% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -23.137% |
| Sunil Healthcare Limited | 1.58 Billion INR | 54.957% |
| Syschem (India) Limited | 1.64 Billion INR | 56.475% |
| Zenith Healthcare Limited | 97.41 Million INR | -632.895% |
| Zenlabs Ethica Limited | 402.58 Million INR | -77.338% |
| Mercury Laboratories Limited | 679.57 Million INR | -5.056% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -88.3% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -91.388% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | 62.155% |
| Roopa Industries Limited | 647.82 Million INR | -10.206% |
| PANJON LTD. | 173.91 Million INR | -310.515% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | 21.838% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -650.531% |
| Anuh Pharma Limited | 4.45 Billion INR | 83.981% |
| Crestchem Limited | 71.44 Million INR | -899.321% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -716.588% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -36.208% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 76.79% |
| Trimurthi Limited | 73.64 Million INR | -869.374% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | 8.278% |
| Norris Medicines Limited | 141.87 Million INR | -403.221% |
| Veerhealth Care Limited | 281.16 Million INR | -153.918% |
| Lactose (India) Limited | 1 Billion INR | 29.13% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -12.979% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 71.469% |
| Gennex Laboratories Limited | 2.29 Billion INR | 68.957% |
| Denis Chem Lab Limited | 1.09 Billion INR | 34.71% |
| Colinz Laboratories Limited | 113.59 Million INR | -528.497% |
| Godavari Drugs Limited | 1.34 Billion INR | 47.019% |
| Zenotech Laboratories Limited | 1.06 Billion INR | 32.779% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | 58.234% |
| Bharat Parenterals Limited | 5.03 Billion INR | 85.83% |
| Coral Laboratories Limited | 2.05 Billion INR | 65.289% |
| Evoq Remedies Limited | 368.61 Million INR | -93.683% |
| Kerala Ayurveda Limited | 1.4 Billion INR | 49.329% |
| Natural Capsules Limited | 3.76 Billion INR | 81.039% |
| Auro Laboratories Limited | 852.67 Million INR | 16.272% |